Fulcrum Therapeutics (FULC) Current Leases (2018 - 2026)

Fulcrum Therapeutics (FULC) has 9 years of Current Leases data on file, last reported at $2.5 million in Q1 2026.

• Current Leases for Q1 2026 came in at $2.5 million, up 9.92% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.5 million (up 9.92% YoY), and the FY2025 annual result was $2.4 million, up 9.97% from the prior year.
• Current Leases rose to $2.5 million in Q1 2026 per FULC's latest filing, from $2.4 million in the prior quarter.
• Over five years, Current Leases peaked at $2.7 million in Q1 2023 and troughed at $2.0 million in Q1 2024.
• A 5-year average of $2.3 million and a median of $2.3 million in 2023 frame the typical range for Current Leases.
• The sharpest annual moves came in 2022 and 2024: Current Leases jumped 60550.0% in 2022, then retreated 23.7% in 2024.
• A 5-year view of Current Leases shows it stood at $2.6 million in 2022, then dropped by 15.76% to $2.2 million in 2023, then declined by 0.27% to $2.2 million in 2024, then increased by 9.97% to $2.4 million in 2025, then increased by 2.37% to $2.5 million in 2026.
• Business Quant data shows FULC's Current Leases at $2.5 million in Q1 2026, $2.4 million in Q4 2025, and $2.3 million in Q3 2025.